Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B1

Food and Chemical Toxicology

Volumn 38, Issue 9, 2000, Pages 793-799

  Enongene, E N ^a   Sharma, R P ^b   Bhandari, N ^b   Voss, K A ^a   Riley, R T ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Fumonisin; Fusarium moniliforme; Gastrointestinal; Kidney; Liver; Sphingolipids

Indexed keywords

ENZYME INHIBITOR; FUMONISIN B1; MYCOTOXIN; SPHINGANINE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE ACYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY EXCRETION; CELL CULTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME INHIBITION; FUSARIUM MONILIFORME; INJECTION; INTESTINE EPITHELIUM CELL; KIDNEY; LIPID METABOLISM; LIVER; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; SMALL INTESTINE;

ANIMALS; CARBOXYLIC ACIDS; FUMONISINS; INJECTIONS, SUBCUTANEOUS; INTESTINE, SMALL; KIDNEY; LIVER; MALE; MICE; MICE, INBRED BALB C; MYCOTOXINS; SPHINGOLIPIDS;

ANIMALIA; FUSARIUM; GIBBERELLA FUJIKUROI; SPHINGIODEA;

EID: 0033868916     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(00)00065-X     Document Type: Article

References (38)

1. 1 mice. a 14-day gavage study Food and Chemical Toxicology. 35:1997;981-989.
2. Dutton M.F. Fumonisins, mycotoxins of increasing importance. their nature and their effects Pharmacology and Therapeutics. 70:1996;137-161.
3. 1, in rats. Carcinogenesis. 12:1991;1247-1251.
4. 1, a toxic metabolite of Fusarium moniliforme. Journal of Veterinary Diagnostic Investigations. 2:1990;217-221.
5. Karlsson K.A. Animal glycolipids as attachment sites for microbes. Chemistry and Physics of Lipids. 42:1986;153-172.
6. 1. Onderstepoort Journal of Veterinary Research. 57:1990;269-275.
7. Merrill A.H., Jr., Schmelz E.M., Dillehay D.L., Spiegel S., Shayman J.A., Schroeder J.J., Riley R.T., Voss K.A., Wang E. Sphingolipids-the enigmatic lipid class: Biochemistry, Physiology, and Pathophysiology. Toxicology and Applied Pharmacology. 142:1997;208-225.
8. Merrill A.H., Jr., Wang E., Mullins R.E., Charles W., Jamison L., Nimkars S., Liotta D.C. Quantitation of free sphingosine in liver by high performance liquid chromatography. Analytical Biochemistry. 171:1988;373-381.
9. 1 in male Sprague-Dawley rats. Natural Toxins. 1:1993;341-346.
10. Norred W.P., Plattner R.D., Dombrink-Kurtzman M.A., Meredith F.I., Riley R.T. Mycotoxin-induced elevation of free sphingoid bases in precision-cut slices. specificity of the response and structure-activity relationships Toxicology and Applied Pharmacology. 147:1997;63-70.
11. 1 on sphingoid base elevation in precision_cut rat liver and kidney slices. Toxicology in Vitro. 10:1996;349-358.
12. 1 in F344/N rats and B6C3F1 mice. NTP TR 496 NIH Publication No. 99-3955.
13. 1 in food-producing animals. Advances in Experimental Medicine and Biology. 392:1996;265-278.
14. Rheeder J.P., Marasas W.F.O., Thiel P.G., Sydenham E.W., Shephard G.S., van Schalkwyk D.J. Fusarium moniliforme and fumonisins in corn in relation to human esophageal cancer in Transkei. Phytopathology. 82:1992;353-357.
15. Riley R.T., An N.H., Showker J.L., Yoo H-S., Norred W.P., Chamberlain W.J., Wang E., Merrill A.H. Jr., Motelin G., Beasley V.R., Haschek W.M. Alteration of tissue and serum sphinganine to sphingosine ratio: An early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicology and Applied Pharmacology. 118:1993;105-112.
16. Riley R.T., Voss K.A., Norred W.P., Sharma R.P., Wang E., Merrill A.H. Jr. Fumonisins. mechanism of mycotoxicity Revue de Médicine Vétérinaire. 149:1998;617-626.
17. Riley R.T., Voss K.A., Norred W.P., Bacon C.W., Meredith F.I., Sharma R.P. Serine palmitoyltransferase inhibition reverses anti-proliferative effects of ceramide synthase inhibition in culture renal cells and suppresses free sphingoid base accumulation in kidney of BALB/c mice. Environmental Toxicology and Pharmacology. 7:1999;109-118.
18. Riley R.T., Wang E., Merrill A.H. Jr. Liquid chromatographic determination of sphinganine and sphingosine. Use of the free sphinganine-to-sphingosine ratio as a biomarker for consumption of fumonisins Journal of AOAC International. 77:1994;533-540.
19. 1 in feeds associated with animal health problems. Mycopathologia. 114:1991;129-135.
20. Sandvig K., Garred O., Van Helvoort A., Van Meer G., Van Deurs B. Importance of glycolipid synthesis for butryic acid-induced sensitization to Shiga toxin and intracellular sorting of toxin in A431 cells. Molecular Biology of the Cell. 7:1996;1391-1404.
21. 1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicology and Applied Pharmacology. 148:1998;252-260.
22. 1. Journal of Comparative Pathology. 117:1997;371-381.
23. Shephard G.S., Thiel P.G., Stockenstrom S., Sydenham E.W. Worldwide survey of fumonisin contamination of corn and corn-based products. Journal of AOAC International. 79:1996;671-687.
24. 1 in rats. Food and Chemical Toxicology. 32:1994;489-491.
25. 2 associated with confirmed cases of equine leukoencephalomalacia. Journal of Agricultural and Food Chemistry. 39:1991;109-111.
26. 1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion. International Journal of Oncology. 14:1999;833-843.
27. 1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. Journal of Biochemical and Molecular Toxicology. 12:1998;281-289.
28. 1 cells. Kidney International. 54:1998;399-406.
29. Ueno Y., Iijima K., Wang S.D., Sugiura Y., Sekijima M., Tanaka T., Chen C., Yu S.Z. Fumonisins as a possible risk factor for primary liver cancer. a 3-year study of corn harvested in Haimen, China, by HPLC and ELISA Food and Chemical Toxicology. 35:1997;1143-1150.
30. Van-Ecten G., Birk R., Brenner-Weis G., Schmidt R.R., Sandhoff K. Modulation of sphingolipid biosynthesis in primary cultured neurons by long chain bases. Journal of Biological Chemistry. 265:1990;9333-9339.
31. 1 in B6C3F1 mice and Fischer 344 rats. Fundamental and Applied Toxicology. 24:1995;102-110.
32. 1 in rats and mice. A review Natural Toxins. 4:1996;16-23.
33. Wang E., Norred W.P., Bacon C.W., Riley R.T., Merrill A.H., Jr. Inhibition of sphingolipid biosynthesis by fumonisins. implications for diseases associated with Fusarium moniliforme Journal of Biological Chemistry. 266:1991;14486-14490.
34. Wang E., Ross P.F., Wilson T.M., Riley R.T., Merrill A.H., Jr. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. Journal of Nutrition. 122:1992;1706-1716.
35. Weiser M.M. Intestinal epithelial cell surface membrane glycoprotein synthesis. Journal of Biological Chemistry. 248:1973;2536-2541.
36. 1 levels associated with an epizootic of equine leukoencephalomalacia. Journal of Veterinary Diagnostic Investigations. 2:1990;213-216.
37. Yoo H.-S., Norred W.P., Showker J.L., Riley R.T. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. Toxicology and Applied Pharmacology. 138:1996;211-218.
38. l cells. Toxicology and Applied Pharmacology. 114:1992;9-15.